Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation: Risk Factors and Diagnostic Methods
Abstract
Introduction: Bronchiolitis Obliterans (BO) is one of the most important pulmonary complications of Hematopoietic Stem Cell Transplantation (HSCT). We decided to evaluate the prevalence and risk factors of BO in HSCT patients in the Shariati Hospital Oncology Research Center.
Materials and Methods: Forty two patients, who had had HSCT for at least 6 months ago, completed the study. The diagnosis of BO was confirmed either by spirometry or inspiratory and expiratory views of HRCT with a FEV1/FVC lower than 75% or more than a 10% drop of FEV1/FVC from a baseline value and mosaic or air trapping on HRCT, respectively.
Results: Nineteen out of forty two patients were BO, with a prevalence of 45.2%; seventeen cases by HRCT and eleven by spirometry criteria. Identified risk factors for BO were acute and chronic GVHD, age 21-40 yrs. Female donor to male recipient and unmatched genders. There was a strong negative predictve value of symptoms under age 20.
Conclusion: Young patients under 20, without respiratory symptoms, need no further evaluation. Acute and chronic GVHD are again the main risk factors regarding female donors to male recipients within the age group of 21-40.
Soubani AO, Miller KB, Hassoun PM. Pulmonary Complications of Bone Marrow Transplantation. Chest, 1996; 109: 1066-1070.
Quabeck K. The Lung as a Critical Organ in Marrow Transplant. Bone Marrow Transplantation, 1994; 14 Suppl 4: S19- 28.
Ostrow D, Buskard N, Hill Rs, et al. Bronchiolitis Complicating Bone Marrow Transplantation. Chest, 1985; 87: 828-830.
Epler GR, Colby TV. The Spectrum of Bronchiolitis Oblitertans. Chest, 1983; 83: 161- 162.
Chien JW, Martin PJ, Gooley TA, et al. Airflow Obstruction after Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation. Am J Resp Critic Care; Med 2003, 168; 208- 214.
Soubani AO, Uberti JP. Bronchiolitis Obliterans Following Hematopoietic Stem Cell Transplantation. ERJ 2007; 29: 1007- 1019.
Marras TK, Szalai JP, Chan CK, et al. Pulmonary Function Abnormalities after Allogeneic Marrow Transplantation: A Systematic Review and Assessment of an Existing Predictive Instrument. Bone Marrow Transplantation, 2002; 30, 599- 607.
Chien JW, Martin PJ, Flowers ME, et al. Implications of Early Airflow Decline after Myeloablative Allogeneic Stem Cell Transplantation. Bone Marrow Transplantation, 2004; 33, 759- 764.
Estenna M, Maurer J, Boehler A. Bronchiolitis Obliterans Syndrome 2001: An Updates of the Diagnostic Criteria. J Heart Lung Transplant. 2002; 21(3): 297-310.
Clark JG, Scwartz DA. Risk Factors for Airflow Obstruction in Recipients of Bone Marrow Transplantation. Ann Int Med, 1987; 107: 648- 656.
Santo Tomas LH, Loberzia F R, Klein JP, et al. Risk Factors for Bronchiolitis Obliterans in Allogeneic Hematopoietic Stem Cell Transplantation for Leukemia. Chest, 2005; 128 (1): 153- 161.
Beinert T, Dull T, Wolfket M. Late Pulmonary Impairment Following Allogeneic Bone Marrow Transplantation. ERJ, 1996; 343- 348.
Chan CK, Hyland RH, hutcheon MA. Risk Factors for Obstructive Airway Disease after Allogeneic Bone Marrow Transplantation. Am Rev Resp, 1988; 137: 111- 118.
Sakaido E, Nanseko C, Harima A. Late Onset non- Infectious Pulmonary Complications after Allogeneic Stem Cell Transplantation. Blood, 2003; 102(12): 4236- 42.
Hadjiliadis D, Duanne D, Steele MP, et al. Gastroesophaeal Refux Disease in” Clinical Transplant 2003; 17: 363- 368.
de Jong PA, Dodd JD, Coxson HO, et al. Bronchiolitis Obliterans Following Lung Transplantation: Early Detection Using Computed Tomographic Scanning. Thorax, 2006; 61: 799- 804.
Files | ||
Issue | Vol 4, No 1 (2010) | |
Section | Articles | |
Keywords | ||
Hematopoetic Stem Cell Transplantation Bronchiolitis Oblitetrans Pulmonary Complications |
Rights and permissions | |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |